Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Astrana Health Reiterates Outlook: Sees 2024 EPS $1.28-$1.52 vs $1.51 Est., Total Revenue $1.65B-$1.85B vs $1.76B Est.

Author: Benzinga Newsdesk | May 07, 2024 05:21pm

Posted In: ASTH